Groupama Asset Managment Purchases 10,895 Shares of HCA Healthcare, Inc. $HCA

Key Points

Error: Response status code does not indicate success: 429 (Too Many Requests).

Groupama Asset Managment raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 23.1% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 58,026 shares of the company's stock after purchasing an additional 10,895 shares during the quarter. Groupama Asset Managment's holdings in HCA Healthcare were worth $19,854,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Cheviot Value Management LLC bought a new stake in shares of HCA Healthcare during the 1st quarter valued at about $26,000. Atwood & Palmer Inc. bought a new position in shares of HCA Healthcare during the 1st quarter valued at approximately $28,000. Bartlett & CO. Wealth Management LLC grew its stake in shares of HCA Healthcare by 888.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after acquiring an additional 80 shares during the period. ORG Partners LLC grew its stake in shares of HCA Healthcare by 344.0% during the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after acquiring an additional 86 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. grew its stake in shares of HCA Healthcare by 75.8% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after acquiring an additional 50 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on HCA shares. JPMorgan Chase & Co. boosted their price target on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. Robert W. Baird boosted their price target on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a report on Thursday, August 14th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Barclays decreased their price objective on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a report on Monday, July 28th. Finally, Morgan Stanley decreased their price objective on HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a report on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat, HCA Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $398.58.

HCA Healthcare Trading Up 0.2%

NYSE:HCA traded up $0.61 during midday trading on Friday, hitting $404.87. 1,081,188 shares of the company traded hands, compared to its average volume of 1,326,629. The firm's fifty day moving average is $373.91 and its 200-day moving average is $354.23. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The firm has a market capitalization of $94.74 billion, a P/E ratio of 17.02, a P/E/G ratio of 1.27 and a beta of 1.39. The company has a current ratio of 0.98, a quick ratio of 0.86 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating the consensus estimate of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.HCA Healthcare's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.